加入官方line@ 加入FB粉絲團
  • 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

健亞

(4130)
可現股當沖
  • 股價
    24.35
  • 漲跌
    ▲0.30
  • 漲幅
    +1.25%
  • 成交量
    241張
  • 產業
    上櫃 生技醫療類股

  • 150人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
健亞 (4130)籌碼相關－富邦-東門 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

富邦-東門 券商分點個股進出

富邦-東門 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/16123.9500.0023.9512160.46%
2024/04/12124.8500.0024.9512150.46%
2024/03/26124.8500.0024.7012260.44%
2024/03/1200.00125.2025.15-1237-0.42%
2023/11/29227.6000.0027.5523140.64%
2023/11/271027.9400.0027.90103213.11%
2023/11/10127.5000.0026.6513440.29%
2023/11/0900.000.127.2027.25-0.1340-0.02%
2023/11/0600.00027.2527.400359-0.01%
2023/11/0300.00026.9026.9003570.00%
2023/11/01026.9500.0026.8503460.01%
2023/10/270.126.6000.0026.550.13320.02%
2023/10/1800.006125.4725.25-61369-16.50%
2023/10/13225.8000.0025.8523840.52%
2023/10/12225.8500.0025.8523940.51%
2023/09/182327.6300.0027.55236153.73%
2023/09/083327.4200.0027.30336604.99%
2023/09/06127.4000.0027.2016880.15%
2023/09/01227.80227.9027.6007070.00%
2023/08/29127.1000.0027.2517490.13%
2023/08/28127.6500.0027.1517850.13%
2023/08/18126.7500.0026.6018940.11%
2023/08/1700.00126.5026.60-1973-0.10%
2023/08/14125.6000.0025.4511,0770.09%
2023/07/27527.9500.0028.1051,2790.39%
2023/07/242027.60127.8027.70191,3971.36%
2023/07/21228.4500.0028.0021,3880.14%
2023/07/19229.25429.0129.00-21,382-0.14%
2023/07/181228.5300.0028.55121,3910.86%
2023/07/1400.000.128.7028.60-0.11,427-0.01%
2023/07/134028.5500.0028.05401,4262.80%
2023/07/12129.1500.0028.7511,4200.07%
2023/07/07229.8000.0029.7521,4520.14%
2023/07/06530.2700.0029.9051,4490.34%
2023/07/0500.00130.8030.85-11,437-0.07%
2023/06/30830.6500.0030.3081,4660.55%
2023/06/29530.3800.0030.7551,4270.35%
2023/06/2800.00830.2030.20-81,403-0.57%
2023/06/27929.822529.9529.70-161,397-1.15%
2023/06/261229.4400.0029.40121,3840.87%
2023/06/202529.8300.0030.15251,3841.81%
2023/06/1300.00129.8029.70-11,381-0.07%
2023/06/0700.00130.3030.30-11,482-0.07%
2023/06/06129.8500.0029.9511,5250.07%
2023/06/02130.4000.0030.2011,5250.07%
2023/05/30129.3000.0029.2011,4750.07%
2023/05/26229.9800.0029.6521,4880.13%
2023/05/25131.00130.8030.8001,4690.00%
2023/05/2400.00331.5331.45-31,446-0.21%
2023/05/2300.00131.8531.30-11,427-0.07%
2023/05/2200.005.230.4030.55-5.21,368-0.38%
2023/05/19129.955029.9629.70-491,339-3.66%
2023/05/1800.00129.5029.55-11,307-0.08%
2023/05/08229.500.129.2529.1021,8310.11%
2023/05/0300.00230.0029.90-21,815-0.11%
2023/04/280.129.05229.2029.30-21,747-0.11%
2023/04/214027.0000.0026.90401,8212.20%
2023/04/19428.105728.5729.10-531,867-2.84%
2023/04/1700.00228.1028.10-22,029-0.10%
2023/04/14128.0000.0027.9512,1010.05%
2023/04/131427.66128.5528.25132,1980.59%
2023/04/12227.8000.0027.9022,2620.09%
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨－2022/09/12
...詳全文
健亞轉投資浩宇超音波D針具追蹤系統 獲美台上市許可UDN聯合新聞網－2022/05/09
健亞（4130）今（9）日宣布，轉投資浩宇生醫公司開發的NAVIRFA（納維爾）超音波3D手術針具追蹤系統，雙雙取得美、......詳全文
健亞轉拓資浩宇NaviFUS®產品 首獲研究用途設備訂單UDN聯合新聞網－2021/03/15
健亞（4130）今（15）日宣布，轉投資的浩宇生醫，下半年將取得肝癌治療產品NAVIRFA®之美國510（k）及台灣二類......詳全文
健亞 相關文章